fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

Give a Holiday Card That Supports the ABTA

Holiday cards for the abta

This holiday season, send a card that spreads joy to loved ones and supports a meaningful cause—each purchase contributes to funding brain tumor research and critical support programs.

Holiday Cards and More

The ABTA is pleased to offer a selection of customizable cards suitable for any occasion. Each box of 25 cards, starting at $35, includes beautiful designs that convey warm holiday wishes or sentiments for other special occasions. A variety of styles and messages are available, so you can find the perfect card to suit your needs. When you purchase these cards, the ABTA receives 40% of the profits, and 100% of any additional donations you choose to make.

To browse and purchase these cards, visit https://www.christmascardfundraising.com/abta/list. Be sure to place your order by December 23 to receive your cards in time for the holidays. Orders typically ship within two to three business days.

Why Choose ABTA Cards?

When you purchase an ABTA card, you’re doing more than sending greetings—you’re supporting life-changing research, patient support, and educational programs for those affected by brain tumors. Every card you send represents a step toward hope, progress, and a brighter future for patients and families.

Thank you for helping the American Brain Tumor Association advance the understanding and treatment of brain tumors through your purchase. Give a holiday card that gives back this season, and let your greetings stand for hope and support.


 

Advancing Brain Tumor Research and Support

Thanks to the generous support of donors like you, the American Brain Tumor Association has invested over $35 million in life-changing brain tumor research, helping pave the way for breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma. Through our Meet Hope Head On campaign, we continue funding critical research and providing free resources for patients and caregivers—bringing hope and advancing care for the brain tumor community.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Double Your Impact for Brain Tumor Families

Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.